Incidence of diabetes following COVID-19 vaccination and SARS-CoV-2 infection in Hong Kong: a population-based cohort study
Background The risk of incident diabetes following Coronavirus Disease 2019 (COVID-19)
vaccination remains to be elucidated. Also, it is unclear whether the risk of incident diabetes …
vaccination remains to be elucidated. Also, it is unclear whether the risk of incident diabetes …
Assessment of the immune response in patients with insulin resistance, obesity, and diabetes to COVID-19 vaccination
J Warpechowski, P Leszczyńska, D Juchnicka… - Vaccines, 2023 - mdpi.com
The SARS-CoV-19 pandemic overwhelmed multiple healthcare systems across the world.
Patients with underlying medical conditions such as obesity or diabetes were particularly …
Patients with underlying medical conditions such as obesity or diabetes were particularly …
Analysis of all-cause hospitalization and death among nonhospitalized patients with type 2 diabetes and SARS-CoV-2 infection treated with molnupiravir or …
Importance Diabetes and COVID-19 are both global pandemics, and type 2 diabetes is a
common comorbidity in patients with acute COVID-19 and is proven to be a key determinant …
common comorbidity in patients with acute COVID-19 and is proven to be a key determinant …
Impaired antibody responses were observed in patients with type 2 diabetes mellitus after receiving the inactivated COVID-19 vaccines
F Xiang, B Long, J He, F Cheng, S Zhang, Q Liu… - Virology Journal, 2023 - Springer
Background Patients with type 2 diabetes mellitus (T2DM) have been reported to be more
susceptible to 2019 novel coronavirus (2019-nCoV) and more likely to develop severe …
susceptible to 2019 novel coronavirus (2019-nCoV) and more likely to develop severe …
Hyperglycemia-triggered lipid peroxidation destabilizes STAT4 and impairs anti-viral Th1 responses in type 2 diabetes
Patients with type 2 diabetes (T2D) are more susceptible to severe respiratory viral
infections, but the underlying mechanisms remain elusive. Here, we show that patients with …
infections, but the underlying mechanisms remain elusive. Here, we show that patients with …
Reduced antibody response to COVID-19 vaccine composed of inactivated SARS-CoV-2 in diabetic individuals
Y Cheng, P Shen, Y Tao, W Zhang, B Xu, Y Bi… - Frontiers in Public …, 2022 - frontiersin.org
Background Patients with type 2 diabetes mellitus (T2DM) are at increased risk for COVID-
19 related morbidity and mortality. Antibody response to COVID-19 vaccine in T2DM …
19 related morbidity and mortality. Antibody response to COVID-19 vaccine in T2DM …
Robust spike-specific CD4+ and CD8+ T cell responses in SARS-CoV-2 vaccinated hematopoietic cell transplantation recipients: a prospective, cohort study
L Federico, THA Tvedt, M Gainullin, JR Osen… - Frontiers in …, 2023 - frontiersin.org
Poor overall survival of hematopoietic stem cell transplantation (HSCT) recipients who
developed COVID-19 underlies the importance of SARS-CoV-2 vaccination. Previous …
developed COVID-19 underlies the importance of SARS-CoV-2 vaccination. Previous …
Research Progress on the Weak Immune Response to the COVID-19 Vaccine in Patients with Type 2 Diabetes
S Yuan, W He, B Liu, Z Liu - Viral Immunology, 2024 - liebertpub.com
Coronavirus Disease 2019 (COVID-19) is generally susceptible to the population, highly
infectious, rapidly transmitted, and highly fatal. There is a lack of specific drugs against the …
infectious, rapidly transmitted, and highly fatal. There is a lack of specific drugs against the …
Early humoral response to COVID-19 vaccination in patients living with obesity and diabetes in France. The COVPOP OBEDIAB study with results from the …
B Gaborit, S Fernandes, P Loubet, L Ninove, A Dutour… - Metabolism, 2023 - Elsevier
Background Patients with diabetes and obesity are populations at high-risk for severe
COVID-19 outcomes and have shown blunted immune responses when administered …
COVID-19 outcomes and have shown blunted immune responses when administered …
Antibody response to inactivated COVID‐19 vaccine in patients with type 2 diabetes mellitus after the booster immunization
H Li, Y Wang, X Li, S Wang, X Feng, X Xiao… - Journal of …, 2023 - Wiley Online Library
Background The immunogenicity of booster inactivated COVID‐19 vaccines in patients with
type 2 diabetes mellitus (T2DM) has remained unclear. Our study aims to investigate the …
type 2 diabetes mellitus (T2DM) has remained unclear. Our study aims to investigate the …